Sfoglia per Autore
Fine mapping and cloning of the breakpoint associated with Menkes syndrome in a female patient.
1992-01-01 Giacomo Consalez G; Gecz J; Stayton CL; Dabovic B; Pasini B; Pezzolo A; Bicocchi MP; Fontes M; Romeo G.
Exon structure and flanking intronic sequences of the human RET proto-oncogene.
1993-01-01 Ceccherini I; Bocciardi R; Yin L; Pasini B; Hofstra R; Takahashi M; Romeo G.
Close linkage with the RET protooncogene and boundaries of deletion mutations in autosomal dominant Hirschsprung disease.
1993-01-01 Yin L; Ceccherini I; Pasini B; Matera I; Bicocchi MP; Barone V; Bocciardi R; Kääriäinen H; Weber D; Devoto M; Romeo G.
DNA polymorphisms and condition for SSCP analysis of the 20 exons of the RET proto-oncogene.
1994-01-01 CECCHERINI I; HOFSTRA RMW; YIN L; STULP RP; BARONE V; STELWAGEN T; BOCCIARDI R; NIJVEEN H; BOLINO A; SERI M; RONCHETTO P; PASINI B; BOZZANO M; BUYS C; ROMEO G.
Heterogeneity and low detection rate of RET mutations in Hirschsprung disease.
1994-01-01 YIN L; BARONE V; SERI M; BOLINO A; BOCCIARDI R; CECCHERINI I; PASINI B; TOCCO T; LERONE M; CYWES S; MOORE S; WANDERWINDEN JM; ABRAMOWICZ MJ; KRISTOFFERSSON U; LARSSON LT; HAMEL BCJ; SILENGO M; MARTUCCIELLO; ROMEO G
Mapping and identification of a candidate gene for Hirschsprung disease: a review.
1994-01-01 Bolino A; Devoto M; Ceccherini I; Puliti A; Pasini B; Bocciardi R; Barone V; Yin L; Martucciello G; Lerone M and Romeo G.
A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.
1994-01-01 Hofstra RM; Landsvater RM; Ceccherini I; Stulp RP; Stelwagen T; Yin L; Pasini B; Höppener JW; van Amstel HK; Romeo G; Lips CJM; Buys C.
Point mutations affecting the tyrosine kinase domain of the RET proto-oo-oncogene in Hirschsprung patients.
1994-01-01 ROMEO G; RONCHETTO P; YIN L; BARONE V; SERI M; CECCHERINI I; PASINI B; BOCCIARDI R; LERONE M; KAARIAINEN H; MARTUCCIELLO G.
Loss of function effect of RET mutations causing Hirschsprung disease.
1995-01-01 PASINI B; BORRELLO MG; GRECO A; BONGARZONE I; LUO Y; MONDELLINI P; ALBERTI L; MIRANDA C; ARIGHI E; BOCCIARDI R; SERI M; BARONE V; RADICE MT; ROMEO G; PIEROTTI MA
Ordering of markers in the pericentromeric region of chromosome 10.
1995-01-01 Hofstra RM; Stelwagen T; Pasini B; van der Veen AY; Ponder BA; Nakamura Y; Romeo G; Buys CH.
The physical map of the human RET proto-oncogene.
1995-01-01 PASINI B ;HOFSTRA RM ;YIN L ;BOCCIARDI R ;SANTAMARIA G ;GROOTSCHOLTEN PM ;CECCHERINI I ;PATRONE G ;PRIOLO M ;BUYS CH
RET activation by germline MEN2A and MEN2B mutations.
1995-01-01 BORRELLO MG; SMITH DP; PASINI B; BONGARZONE I; GRECO A; LORENZO MJ; ARIGHI E; MIRANDA C; ENG C; ALBERTI L; BOCCIARDI R; MONDELLINI P; SCOPSI L; ROMEO G; PONDER BAJ; PIEROTTI MA.
Malignant pheochromocytoma in multiple endocrine neoplasia type 2B syndrome. Case report and review of the literature.
1996-01-01 SCOPSI L; CASTELLANI MR; GULLO M; CUSUMANO F; CAMERINI E; PASINI B; OREFICE S.
RET mutations in human disease.
1996-01-01 Pasini B; Ceccherini I; Romeo G.
The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma
1996-01-01 BORRELLO M.G.; ALBERTI L.; ARIGHI E.; BONGARZONE I.; BATTISTINI C.; BARDELLI A.; PASINI B.; PIUTTI C.; RIZZETTI M.G.; MONDELLINI P.; RADICE M.T.; PIEROTTI M.A.
Frequency of RET mutations in long- and short-segment Hirschsprung disease.
1997-01-01 Seri M; Yin L; Barone V; Bolino A; Celli I; Bocciardi R; Pasini B; Ceccherini I; Lerone M; Kristoffersson U; Larsson LT; Casasa JM; Cass DT; Abramowicz MJ; Vanderwinden JM; Kravcenkiene I; Baric I; Silengo M; Martucciello G; Romeo G.
Identification of Shc docking site on Ret tyrosine kinase.
1997-01-01 ARIGHI E; ALBERTI L; TORRITI F; GHIZZONI S; RIZZETTI MG; PELICCI G; PASINI B; BONGARZONE I; PIUTTI C; PIEROTTI MA; BORRELLO MG.
The multiple endocrine neoplasia type 2B point mutation switches the specificity of the Ret tyrosine kinase towards cellular substrates that are susceptible to interact with Crk and Nck.
1997-01-01 Bocciardi R; Mograbi B; Pasini B; Borrello MG; Pierotti MA; Bourget I; Fischer S; Romeo G; Rossi B.
Somatic in frame deletions not involving juxtamembranous cysteine residues strongly activate the RET proto-oncogene.
1997-01-01 Ceccherini I; Pasini B; Pacini F; Gullo M; Bongarzone I; Romei C; Santamaria G; Matera I; Mondellini P; Scopsi L; Pinchera A; Pierotti MA; Romeo G.
BRCA1 and BRCA2 germline mutations in early-onset breast carcinoma patients.
1998-01-01 Conti AR; De Benedetti MVG; Stagi L; Mondini P; Pasini B; Pensotti V; Spatti GB; Rilke F; Pierotti MA; Radice P.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Fine mapping and cloning of the breakpoint associated with Menkes syndrome in a female patient. | 1992 | Giacomo Consalez G; Gecz J; Stayton CL; Dabovic B; Pasini B; Pezzolo A; Bicocchi MP; Fontes M; Romeo G. | |
| Exon structure and flanking intronic sequences of the human RET proto-oncogene. | 1993 | Ceccherini I; Bocciardi R; Yin L; Pasini B; Hofstra R; Takahashi M; Romeo G. | |
| Close linkage with the RET protooncogene and boundaries of deletion mutations in autosomal dominant Hirschsprung disease. | 1993 | Yin L; Ceccherini I; Pasini B; Matera I; Bicocchi MP; Barone V; Bocciardi R; Kääriäinen H; Weber D; Devoto M; Romeo G. | |
| DNA polymorphisms and condition for SSCP analysis of the 20 exons of the RET proto-oncogene. | 1994 | CECCHERINI I; HOFSTRA RMW; YIN L; STULP RP; BARONE V; STELWAGEN T; BOCCIARDI R; NIJVEEN H; BOLINO A; SERI M; RONCHETTO P; PASINI B; BOZZANO M; BUYS C; ROMEO G. | |
| Heterogeneity and low detection rate of RET mutations in Hirschsprung disease. | 1994 | YIN L; BARONE V; SERI M; BOLINO A; BOCCIARDI R; CECCHERINI I; PASINI B; TOCCO T; LERONE M; CYWES S; MOORE S; WANDERWINDEN JM; ABRAMOWICZ MJ; KRISTOFFERSSON U; LARSSON LT; HAMEL BCJ; SILENGO M; MARTUCCIELLO; ROMEO G | |
| Mapping and identification of a candidate gene for Hirschsprung disease: a review. | 1994 | Bolino A; Devoto M; Ceccherini I; Puliti A; Pasini B; Bocciardi R; Barone V; Yin L; Martucciello G; Lerone M and Romeo G. | |
| A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. | 1994 | Hofstra RM; Landsvater RM; Ceccherini I; Stulp RP; Stelwagen T; Yin L; Pasini B; Höppener JW; van Amstel HK; Romeo G; Lips CJM; Buys C. | |
| Point mutations affecting the tyrosine kinase domain of the RET proto-oo-oncogene in Hirschsprung patients. | 1994 | ROMEO G; RONCHETTO P; YIN L; BARONE V; SERI M; CECCHERINI I; PASINI B; BOCCIARDI R; LERONE M; KAARIAINEN H; MARTUCCIELLO G. | |
| Loss of function effect of RET mutations causing Hirschsprung disease. | 1995 | PASINI B; BORRELLO MG; GRECO A; BONGARZONE I; LUO Y; MONDELLINI P; ALBERTI L; MIRANDA C; ARIGHI E; BOCCIARDI R; SERI M; BARONE V; RADICE MT; ROMEO G; PIEROTTI MA | |
| Ordering of markers in the pericentromeric region of chromosome 10. | 1995 | Hofstra RM; Stelwagen T; Pasini B; van der Veen AY; Ponder BA; Nakamura Y; Romeo G; Buys CH. | |
| The physical map of the human RET proto-oncogene. | 1995 | PASINI B ;HOFSTRA RM ;YIN L ;BOCCIARDI R ;SANTAMARIA G ;GROOTSCHOLTEN PM ;CECCHERINI I ;PATRONE G ;PRIOLO M ;BUYS CH | |
| RET activation by germline MEN2A and MEN2B mutations. | 1995 | BORRELLO MG; SMITH DP; PASINI B; BONGARZONE I; GRECO A; LORENZO MJ; ARIGHI E; MIRANDA C; ENG C; ALBERTI L; BOCCIARDI R; MONDELLINI P; SCOPSI L; ROMEO G; PONDER BAJ; PIEROTTI MA. | |
| Malignant pheochromocytoma in multiple endocrine neoplasia type 2B syndrome. Case report and review of the literature. | 1996 | SCOPSI L; CASTELLANI MR; GULLO M; CUSUMANO F; CAMERINI E; PASINI B; OREFICE S. | |
| RET mutations in human disease. | 1996 | Pasini B; Ceccherini I; Romeo G. | |
| The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma | 1996 | BORRELLO M.G.; ALBERTI L.; ARIGHI E.; BONGARZONE I.; BATTISTINI C.; BARDELLI A.; PASINI B.; PIUTTI C.; RIZZETTI M.G.; MONDELLINI P.; RADICE M.T.; PIEROTTI M.A. | |
| Frequency of RET mutations in long- and short-segment Hirschsprung disease. | 1997 | Seri M; Yin L; Barone V; Bolino A; Celli I; Bocciardi R; Pasini B; Ceccherini I; Lerone M; Kristoffersson U; Larsson LT; Casasa JM; Cass DT; Abramowicz MJ; Vanderwinden JM; Kravcenkiene I; Baric I; Silengo M; Martucciello G; Romeo G. | |
| Identification of Shc docking site on Ret tyrosine kinase. | 1997 | ARIGHI E; ALBERTI L; TORRITI F; GHIZZONI S; RIZZETTI MG; PELICCI G; PASINI B; BONGARZONE I; PIUTTI C; PIEROTTI MA; BORRELLO MG. | |
| The multiple endocrine neoplasia type 2B point mutation switches the specificity of the Ret tyrosine kinase towards cellular substrates that are susceptible to interact with Crk and Nck. | 1997 | Bocciardi R; Mograbi B; Pasini B; Borrello MG; Pierotti MA; Bourget I; Fischer S; Romeo G; Rossi B. | |
| Somatic in frame deletions not involving juxtamembranous cysteine residues strongly activate the RET proto-oncogene. | 1997 | Ceccherini I; Pasini B; Pacini F; Gullo M; Bongarzone I; Romei C; Santamaria G; Matera I; Mondellini P; Scopsi L; Pinchera A; Pierotti MA; Romeo G. | |
| BRCA1 and BRCA2 germline mutations in early-onset breast carcinoma patients. | 1998 | Conti AR; De Benedetti MVG; Stagi L; Mondini P; Pasini B; Pensotti V; Spatti GB; Rilke F; Pierotti MA; Radice P. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile